Psychedelic Stocks,Shroom News COMPASS Pathways Acquires Intellectual Property of Novel Psychedelics Compounds and Prodrugs By Dennis Mutua September 15, 2021 Mental healthcare company focusing on speeding patient access to evidence based innovation in mental health COMPASS Pathways PLC. (CMPS) announced having acquired an intellectual property (IP) platform comprising of patent applica...
Psychedelic Stocks,Shroom News NeonMind Completes Sale of Consumer Related and Other Non-Core Assets By Dennis Mutua September 14, 2021 Pharmaceutical company focusing on preclinical research to develop potential clinical treatments and wellness products to address obesity and metal conditions NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) announced having c...
Psychedelic Stocks,Shroom News Hamilton Morris Joins COMPASS Pathways as a Full Time Consultant By Dennis Mutua September 13, 2021 Mental healthcare company focusing on accelerating access of evidence-based innovation by mental health patients COMPASS Pathways PLC. (CMPS) announced having reached out to Mr. Hamilton Morris, a research scientist and a film mak...
Psychedelic Stocks,Shroom News Levitee Labs Starts Trading in the United States OTC Markets By Dennis Mutua September 10, 2021 Integrated wellness company offering medicines and novel psychedelics therapies for mental conditions Levitee Labs Inc. (CSE: LVT) (OTCPK: LVTTF) announced having commenced trading on the United States Over-The-Counter (OTC) marke...
Psychedelic Stocks,Shroom News CaamTech Raises $22M in a Series A Financing Round For Psychedelics Drug Development By Dennis Mutua September 09, 2021 Drug discovery and lead optimization company focused on coming up with psychedelics drugs which treat mental health conditions and other unmet conditions CaamTech Inc. announced having raised $22 million from a recently concluded ...
Psychedelic Stocks,Shroom News Nova Mentis Expands Psilocybin Program Targeting Obesity and Diabetes By Dennis Mutua September 08, 2021 Biotechnology company focusing on developing diagnostics and psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Sciences Corp. (CSE: NOVA) (OTCQB: NMLSF) says that it has e...
Psychedelic Stocks,Shroom News Blue Sun Mycology Submits Patent Application for Methods Related to Novel Species of Psychoactive Fungi By Dennis Mutua September 07, 2021 Biotech breeding company focusing on development and commercialization of novel species that have naturally extracted compounds which may be deemed to have medicinal benefits Blue Sun Mycology Group announced having filed a patent...
Psychedelic Stocks,Shroom News Filament Health Corp Submits its 20th Patent Application By Dennis Mutua September 03, 2021 Exclusively natural psychedelics drug discovery and extraction technology company Filament Health Corp. (NEO: FH) announced having submitted its 20th patent application in support of it research phase programs. This latest pate...